Naser Danan, MD
- Clinical Instructor
Patient Satisfaction Reviews
4.9 out of 5
Patient Comments (7)
Reviewed On 5/1/2020
My son has seen Dr.Danan for nearly 18 years. He is a very concerned and compassionate doctor who exhibits love and care to our entire family. We are fortunate to call him "our pediatrician".
Reviewed On 3/6/2020
Dr. Danan is a wonderful, thoughtful Doctor. he us very thorough and kind
Reviewed On 2/15/2020
best peds group always excellent care
Reviewed On 1/17/2020
Dr. Danan is the absolute best.. Very kind, caring, always listening what my concerns are for my son.. He's awesome!!
Reviewed On 10/13/2019
Always a great experience with Dr Danan. Thank you.
Reviewed On 9/16/2019
Dr. Danan went above & beyond! He spent time talking with my son after the exam was completed and it's evident that he genuinely cares about his patients.
Reviewed On 8/5/2019
Dr. Danan is the best pediatrician! He knows [...], is thoughtful in his assessment, and consistently positive in his approach with children.
- Pediatrics - American Board of Pediatrics
Fellowship | Pediatric Hematology/Oncology
Pediatric Hematology/Oncology - University Hospitals Of Cleveland (1991 - 1992)
Residency | Pediatrics
Pediatrics - University Hospitals Of Cleveland (1989 - 1991)
Internship | Pediatrics
Pediatrics - University Hospitals Of Cleveland (1988 - 1989)
University Of Damascus Faculty Of Medicine (1985)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Naser Danan did not disclose any Outside Relationships with Industry.